New horizons in platelets flow cytometry

Malaysian Journal of Medical Sciences

Volumn 20, Issue 2, 2013, Pages 63-67

  Saboor, Muhammad ^a   Moinuddin, Moinuddin ^a   Ilyas, Samina ^a  

^a BAQAI MEDICAL UNIVERSITY   (Pakistan)

Author keywords

CD62; CD63; Flow cytometry; Platelets

Indexed keywords

ANTITHROMBOCYTIC AGENT; PADGEM PROTEIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG MONITORING; FLOW CYTOMETRY; HUMAN; INCUBATION TIME; RELIABILITY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE ACTIVATION; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; THROMBOSIS;

EID: 84874590886     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Orfao A, Ruiz-Arguelles A, Lacombe F, Ault K, Basso G, Danova M. Flow cytometry: its applications in hematology. Haematologica. 1995;80(1):69-81.
2. Harrison P. Assessment of platelet function in the laboratory. Hamostaseologie. 2009;29(1):25-31.
3. Matzdorff AC. Platelet function tests and flow cytometry to monitor antiplatelet therapy. Semin Thromb Hemost. 2005;31(4):393-399.
4. Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol. 1999;6(5):342-348.
5. Pakala R, Waksman R. Currently available methods for platelet function analysis: advantages and disadvantages. Cardiovasc Revasc Med. 2011;12(5): 312-322.
6. Ault KA. The clinical utility of flow cytometry in the study of platelets. Seminars in hematology. 2001;38(2):160-168.
7. Linden MD, Frelinger AL, Barbard MR, Przyklenk K, Furman MI, Michelson AD. Application of flow cytometry to platelet disorders. Semin Thromb Hemost. 2004;30(5):501-511.
8. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001;104(13):1533-1537.
9. Sbrana S, Pina DF, Rizza A, Buffa M, Filippis DR, Gianetti J, et al. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. Cytometry B Clin Cytom. 2008;74B(1):30-39.
10. Huang KJ, Yang YC, Lin YS, Liu HS, Yeh TM, Chen SH, et al. Flow cytometric determination for Dengue virus-infected cells: its application for antibodydependent enhancement study. Dengue Bulletin. 2005;29:142-148.
11. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol. 2001;63(2):143-149.
12. Michelson AD, Linden MD, Barnard MR, Furman MI, Frelinger AL. Flow cytometry. In: Michelson, editor. Platelets. 2nd ed. San Diego (CA): Elsevier Academic Press. 2007. p. 545-564.
13. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb- IIIa complex during platelet activation. J Biol Chem. 1985;260(20):11107-11114.
14. McEver RP. P-Selectin/PSGL-1 and other interactions between platelets, leukocytes, and endothelium. In: Michelson AD, editor. Platelets. 2nd ed. San Diego (CA): Elsevier Academic Press. 2007. p. 231-249.
15. Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood. 1987;70(3): 838-845.
16. Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemost. 1991;65(5):467-473.
17. Salvagno GL, Montagnana M, Degan M, Marradi Pl, Ricetti MM, Riolfi P, et al. Evaluation of platelet turnover by flow cytometry. Platelets. 2006;17(3): 170-177.
18. Yamaguchi K, Nomura S, Kido H, Kawakatsu T, Fukuroi T, Suzuki M, et al. Flow cytometric analysis of changes in cytoskeletal proteins during platelet destruction and activation using a monoclonal antibody against platelet myosin. Am J Hematol. 1993;44(2):106-111.
19. Ritchie JL, Alexander HD, Rea IM. Flow cytometry analysis of platelet P-selectin expression in whole blood-methodological considerations. Clin Lab Haematol. 2000;22(6):359-363.
20. Chae H, Park HH. EDTA inhibits the binding of clone 96.2C1, an anti-CD41a monoclonal antibody, to the platelets and addition of heparin and CaCl2 to the antibody neutralizes the EDTA-induced inhibitory effect. Korean J Hematol. 2009;44(1):42-46.
21. Schmitz G, Rothe G, Rufl A, Bariage S, Tschope D, Clemetson KJ, et al. European Working Group on Clinical Cell Analysis: Consensus Protocol for the Flow Cytometric Characterisation of Platelet Function. Thromb Haemost. 1998;79(5):885-896.
22. Schmidt V, Hilberg T, Franke G, Glase D, Gabriel HH. Paraformaldehyde fixation induces a systematic activation of platelets. Platelets. 2003;14(5): 287-294.
23. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface p-selectin but continue to circulate and function. Proc Natl Acad Sci USA. 1996;93(21):11877-11882.
24. Rinder HM. Platelet function testing by flow cytometry. Clin Lab Sci. 1998;11(6):365-372.
25. Hu H, Daleskog M, Li N. Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding. Thromb Res. 2000;100(3):161-166.
26. Cahill M, Macey R, Newland AC. Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P-selectin (CD62) and GP53 (CD63). BJH. 1993; 84 (3):527-529.
27. Atar OD, Eisert C, Pokov I, Serebruany VL. Stability validation of paraformaldehyde-fixed samples for the assessment of the platelet PECAM-1, P-selectin, and PAR-1 thrombin receptor by flow cytometry. J Thromb Thrombolysis. 2010;30(1):79-83.
28. Hagberg IA, Lyberg T. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platlets. 2000;11(3):137-150.
29. Saboor M, Moinuddin M, Ilyas S. Flow cytometry based chronologic analysis of surface glycoproteins of resting and stimulated platelets in normal individuals. Pak J Med Sci. 2012;28(4):625-629.
30. Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33(11): 2570-2574.
31. Van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem. 2006;52(4):657-664.
32. Tan KT, Tayebjee MH, Lynd C, Blann AD, Lip GY. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med. 2005;37(1):61-66.
33. Chang I, Choudhury A, Patel J, Lip GY. Soluble, platelet-bound and total P-selectin as indices of platelet activation in congestive heart failure. Ann Med. 2009;41(1):45-51.
34. Belniak-Legiec E, Stelmasiak Z. Blood platelet activation markers in patients with acute cerebral infarction during the earliest stage of the disease---evaluation using flow cytometry methods. Neurol Neurochir Pol. 2000;34(5):853-864.
35. Cha JK, Jo WS, Shin HC, Bae HR, Ho JM, Kim JW. Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke. Platelets. 2004;15(1):3-7.
36. Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, Huang CR, et al. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Thromb Res. 2009;124(2):213-218.
37. Matzdroff AC, Kuhnel G, Kemkes-Matthes B, Pralle H, Voss R, Fareed J. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro. J Lab Clin Med. 2000;135(3):247-255.